Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tivozanib (KRN951) is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 76.00 | |
25 mg | In stock | $ 145.00 | |
50 mg | In stock | $ 252.00 | |
100 mg | In stock | $ 450.00 | |
200 mg | In stock | $ 663.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Tivozanib (KRN951) is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities. |
Targets&IC50 | PDGFRα:40 nM, EphB2:24 nM, VEGFR1:30 nM, VEGFR3:15 nM, VEGFR2:6.5 nM |
Kinase Assay | Kinase Assays: Cell-free kinase assays are done in quadruplicate with 1 μM ATP to determine the IC50 values of AV-951 against a variety of recombinant receptor and nonreceptor tyrosine kinases including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFRβ, Flt-3 and FGFR1. |
Cell Research | Human umbilical vein endothelial cells (HUVEC) and normal human dermal fibroblasts-based assays are done to determine the ability of AV-951 to inhibit ligand-dependent phosphorylation of tyrosine kinase receptors. The cells are starved overnight in appropriate basic medium containing 0.5% fetal bovine serum (FBS). The cells are incubated for 1 hour following the addition of AV-951 or 0.1% DMSO, and then stimulated with the cognate ligand at 37 °C. Receptor phosphorylation is induced for 5 minutes except for VEGFR3 (10 minutes), c-Met (10 minutes), and c-Kit (15 minutes). All the ligands used in the assays are human recombinant proteins, except for VEGF-C, a rat recombinant protein. Following cell lysis, receptors are immunoprecipitated with appropriate antibodies and subjected to immunoblotting with phosphotyrosine. Quantification of the blots and calculation of IC50 values are carried ou(Only for Reference) |
Synonyms | AV-951, KRN951 |
Molecular Weight | 454.86 |
Formula | C22H19ClN4O5 |
CAS No. | 475108-18-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 16 mg/mL (35.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tivozanib 475108-18-0 Angiogenesis Tyrosine Kinase/Adaptors VEGFR Ephrin Receptor PDGFR antitumor vascular permeability renal cell carcinoma AV951 AV-951 angiogenesis AV 951 Inhibitor Vascular endothelial growth factor receptor KRN951 KRN 951 orally active inhibit KRN-951 inhibitor